How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Kinase Biology Services Market
- By Service Type: Kinase Profiling, Kinase Assay Development, High-Throughput Screening (HTS), Kinase Inhibitor Screening, Mechanism of Action Studies
- By Target Kinase Class: Tyrosine Kinases, Serine/Threonine Kinases, Lipid Kinases, Dual-Specificity Kinases, Mitogen-Activated Protein Kinases (MAPKs)
- By End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories
- By Technology Platform: Fluorescence Resonance Energy Transfer (FRET) Assays, Radiometric Assays, Mass Spectrometry-Based Assays, Surface Plasmon Resonance (SPR), Cell-Based Kinase Assays
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Kinase Profiling leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Kinase Biology Services Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Target Kinase Class 5
End-User 4
Technology Platform 5
Companies profiled
Thermo Fisher Scientific
Charles River Laboratories
Eurofins Scientific
WuXi AppTec
Covalab
BPS Bioscience
Reaction Biology Corporation
Carna Biosciences
SignalChem Lifesciences
ProQinase
DiscoverX (a part of Eurofins)
Selleck Chemicals
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Charles River Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →WuXi AppTec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Covalab
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BPS Bioscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Reaction Biology Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Carna Biosciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →SignalChem Lifesciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ProQinase
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →DiscoverX (a part of Eurofins)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Selleck Chemicals
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Caliper Life Sciences (PerkinElmer)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Cisbio Bioassays
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Invitrogen (Thermo Fisher Scientific)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,424M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Kinase Profiling33.9
- Kinase Assay Development18.9
- High-Throughput Screening (HTS)16.4
- Kinase Inhibitor Screening19.8
- Mechanism of Action Studies11.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,480M → $1,946M · 3.5%
Europe$1,031M → $1,580M · 5.5%
Asia Pacific$941.7M → $1,230M · 3.4%
Latin America$583.0M → $834.9M · 4.6%
Middle East and Africa$448.4M → $678.6M · 5.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.542026
4.562027
4.562028
4.592029
4.592030
4.612031
4.622032
4.632033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific15.3
- Charles River Laboratories23.9
- Eurofins Scientific5.7
- WuXi AppTec9.0
- Covalab9.9
- BPS Bioscience8.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type11.9%
Target Kinase Class21.6%
End-User28.7%
Technology Platform37.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe25.2
- Asia Pacific19.6
- Latin America13.3
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 98 | 96 | 90 | 89 | 95 | 97 | 94 |
| Charles River Laboratories | 84 | 83 | 71 | 86 | 86 | 78 | 81 |
| Eurofins Scientific | 77 | 67 | 66 | 80 | 69 | 84 | 74 |
| WuXi AppTec | 65 | 59 | 78 | 73 | 65 | 82 | 70 |
| Covalab | 73 | 67 | 66 | 56 | 56 | 75 | 66 |
| BPS Bioscience | 59 | 52 | 61 | 60 | 52 | 51 | 56 |
| Reaction Biology Corporation | 41 | 40 | 45 | 48 | 45 | 62 | 47 |
| Carna Biosciences | 58 | 49 | 45 | 55 | 53 | 50 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Charles River Laboratories
- Eurofins Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Charles River Laboratories | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Eurofins Scientific | ◐ | − | ◐ | ✓ | ✓ | ✓ |
| WuXi AppTec | ✓ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Covalab | ◐ | ◐ | − | − | − | − |
| BPS Bioscience | ◐ | ◐ | − | ◐ | ◐ | − |
| Reaction Biology Corporation | − | − | − | − | − | ◐ |
| Carna Biosciences | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific94
2Charles River Laboratories81
3Eurofins Scientific74
4WuXi AppTec70
5Covalab66
6BPS Bioscience56
7Carna Biosciences52
8Reaction Biology Corporation47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificCharles River Laboratories
Challenger2
Strong scale, closing on the leaders.
Eurofins ScientificWuXi AppTec
Contender1
Focused players with pockets of strength.
Covalab
Niche3
Specialists in a single segment or region.
BPS BioscienceReaction Biology CorporationCarna Biosciences
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Kinase Biology Services Market — a $418M beachhead inside a $6.62B market.
Beachhead (SOM)$418Mobtainable near-term
Serviceable (SAM)$2.43Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Kinase Profiling
Best fit — highest urgency & budget in Service Type.
Economic buyer76 fit
Kinase Assay Development
Strong fit — clear ROI and a fast path to value.
End user67 fit
High-Throughput Screening (HTS)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Target Kinase Class & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Kinase Biology Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified25%
Evaluation11%
Closed-won6%
$17.7KCAC
$60KLTV
3.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Kinase Biology Services Market is a high-growth opportunity — $6.07B by 2033, compounding at 11.4%.
TAM · 2025$2.56Btoday
TAM · 2033$6.07Bforecast
CAGR11.4%2027–2033
Cumulative$36.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.07BTotal addressable market
SAM$2.14BServiceable available market
SOM$435MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.4% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.07BLarge & growingTAM by 2033 at 11.4% CAGR
$2.14BServiceable nowreachable with today’s model
$435MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.74BBear7.4% CAGR
$6.07BBase11.4% CAGR
$7.77BBull15.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Target Kinase Class optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Kinase Biology Services Market — a $1.74B market by 2033. Plan: grow share from 10.0% to 17.4%.
Market size · 2033$1.74Btotal addressable
Market CAGR11.4%2027–2033
Target share17.4%from 10.0% today
Revenue ambition$303Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.0% | 17.4% | Behind |
| Revenue | $170M | $303M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 36.5% | 44.5% | Ahead |
| Customer retention | 86.0% | 95.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Target Kinase Class capability
A defensible second engine — invest in Target Kinase Class to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Target Kinase Class
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $34M capacity & capability investment
- Greenlight bolt-on M&A in Target Kinase Class
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Kinase Biology Services Market conversation — a $1.15B market you can size, segment and defend in minutes.
Market size · 2033$1.15Btotal opportunity
Growth3.3%CAGR to 2033
Addressable buyers942+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 2 mopayback period
$83K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificCharles River LaboratoriesEurofins ScientificWuXi AppTecCovalabBPS BioscienceReaction Biology CorporationCarna Biosciences+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Kinase Biology Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Kinase Biology Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Killer Cell Immunoglobulin Like Receptor (KIR) Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportKilled-type Poultry Vaccine Market
Market size, share, segmentation and regional forecast.
$818M market · 2025 base year
View reportKids Wheelchair Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportKids Water Flosser Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportKids Sports Injury Treatment Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportKids Orthodontics Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportKidney Trays Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportKidney Transplant Rejection Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportKidney Transplant Medicine Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportKidney Stone Stopper Supplement Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportKidney Stone Management Device Market
Market size, share, segmentation and regional forecast.
$817M market · 2025 base year
View reportKidney Stone Extraction Silicone Balloons Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.